Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2011:2011:920807.
doi: 10.1155/2011/920807. Epub 2011 Mar 9.

Acupuncture treatment for bortezomib-induced peripheral neuropathy: a case report

Ting Bao  1 , Ruixin Zhang, Ashraf Badros, Lixing Lao
Affiliations
Case Reports

Acupuncture treatment for bortezomib-induced peripheral neuropathy: a case report

Ting Bao et al. Pain Res Treat. 2011.

Abstract

Peripheral neuropathy is a common and severe dose-limiting side effect of the chemotherapy agent, bortezomib, in multiple myeloma patients. Treatment with narcotics, antidepressants, and anticonvulsants has limited response and potential significant side effects. Acupuncture has been reported to be effective in treating diabetic neuropathy and chemo-induced peripheral neuropathy. There has not been report on the effect of acupuncture in treating bortezomib-induced peripheral neuropathy specifically. Here, we report a successful case of using acupuncture to relieve bortezomib-induced peripheral neuropathy symptoms.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Acupuncture protocol to treat bortezomib-induced peripheral neuropathy.
See this image and copyright information in PMC

References

    1. San Miguel J, Bladé J, Boccadoro M, et al. A practical update on the use of bortezomib in the management of multiple myeloma. Oncologist. 2006;11(1):51–61. - PubMed
    1. Argyriou AA, Iconomou G, Kalofonos HP. Bortezomib-induced peripheral neuropathy in multiple myeloma: a comprehensive review of the literature. Blood. 2008;112(5):1593–1599. - PubMed
    1. Badros A, Goloubeva O, Dalal JS, et al. Neurotoxicity of bortezomib therapy in multiple myeloma: a single-center experience and review of the literature. Cancer. 2007;110(5):1042–1049. - PubMed
    1. Richardson PG, Briemberg H, Jagannath S, et al. Frequency, characteristics, and reversibility of peripheral neuropathy during treatment of advanced multiple myeloma with bortezomib. Journal of Clinical Oncology. 2006;24(19):3113–3120. - PubMed
    1. Chaudhry V, Cornblath DR, Polydefkis M, Ferguson A, Borrello I. Characteristics of bortezomib- and thalidomide-induced peripheral neuropathy: research report. Journal of the Peripheral Nervous System. 2008;13(4):275–282. - PMC - PubMed

Publication types

LinkOut - more resources